Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Multiple-dose rhLAMAN (Lamazym) in alpha-mannosidosis
2010-022085-26Phase 2Completed
- Sponsor
- Zymenex
- Start
- Aug 2010
- Modality
- Replacement Enzymes → Therapeutic Enzymes → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of velmanase alfa in alpha-mannosidosis (2 arms), sponsored by Zymenex. Primary endpoint: Efficacy endpoints. Started Aug 2010; status: completed.
02
Drugs
velmanase alfa
03
Conditions
alpha-mannosidosis
Beyond the preview
Go deeper on 2010-022085-26.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-022085-26.